18 Sep, 2018 · In News
06 Dec, 2018 · In Press Releases
World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies
05 Oct, 2018
Bioservo Technologies has received an order regarding delivery and implementation of Ironhand® worth approximately SEK 0,5 million. The buyer is one of the world’s foremost digital industrial enterprises. Throughout last year, the customer has successfully tested and evaluated Bioservo’s innovative technology to ensure it is suitable for all parts of their production.
Ironhand® is the world’s first soft robotic muscle strengthening system for professional users. Ironhand® strengthens the worker’s grip and stamina and has been developed to prevent and detect the risk of stress injuries in grip-intensive and repetitive work operations.
Bioservo believes digital human augmentation is the way forward in creating an ergonomic and sustainable work environment and thus profitability through corporate responsibility.
“We are very happy that this customer is satisfied with our technology and has chosen to start the implementation phase within their organisation, and we look forward to continuing our cooperation. The work environment on the factory floor can clearly benefit from Ironhand® as it combines both muscle strengthening technology as well as digitalization of ergonomical risk assessment. We have seen an inreasing demand for our concept across many industries, says Petter Bäckgren, CEO at Bioservo Technologies.”
Delivery and implementation is expected to start before the end of 2018.
About Bioservo Technologies AB
Bioservo Technologies (publ) is a technology and development company that combines medical science with modern robotics. The company has a leading global position within soft exoskeleton technology, wearable non-invasive products, for people in need of extra power to support the body's endurance and performance, or for people with reduced muscular strength.
After many years of research and development, Bioservo Technologies now focus on the commercialization of its products and patented technologies. The developed gloves are well suited for both rehabilitation within health and medical care and preventively for professionals in the industry. The company has signed strategic cooperation agreements with several multinational companies within e.g. the automobile, aircraft as well as the construction and infrastructure industry.
Bioservo Technologies was founded in 2006 through a collaboration between researchers at the Royal Institute of Technology and doctors at Karolinska University Hospital in Stockholm. Bioservo Technologies is a Swedish public company with headquarters and operations in Kista, north of Stockholm. FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North.
For more information, please visit www.bioservo.se
Bioservo Technologies AB Press Contacts
Tel.: +46 (0)70 555 69 97
Sales and Marketing Director
Tel.: +46 (0)70 467 57 84